Vol 11, No 6 (December 31, 2022): Chinese Clinical Oncology

Original Article

A prospective cohort study of TIMP1 as prognostic biomarker in gastric and colon cancer
Filipa Castro Macedo, Nuno Cunha, Tatiana Cunha Pereira, Rita Felix Soares, Ana Raquel Monteiro, Nuno Bonito, Frederico Valido, Gabriela Sousa
High local control and low ocular toxicity using ultra-low-dose “boom-boom” radiotherapy for indolent orbital lymphoma
Sanjna Shelukar, Christian Fernandez, Zeynep Bas, Lydia Komarnicky, Sara E. Lally, Carol L. Shields, Adam Binder, Pierluigi Porcu, Onder Alpdogan, Ubaldo Martinez-Outschoorn, Wenyin Shi

Editorial Commentary

GEMSTONE-302: “If you keep doing the same thing you get the same result”
Mengni Guo, Jieying Liu, Tarek Mekhail, Mark A. Socinski
The role of traditional, complementary, and alternative medicine in cancer care in the Philippines
Ma. Veronica Pia N. Arevalo, Janine Patricia G. Robredo, Sary Valenzuela, Frances Dominique Velasco Ho, Nicole Rose I. Alberto, Isabelle Rose I. Alberto, Madeleine Nicole G. Bernardo, Katherine Donatela Manlongat, Ann Meredith U. Garcia, Jaime Z. Galvez Tan, Edward Christopher Dee, Michelle Ann B. Eala

Disclosure:

1. The series “Interviews with Outstanding Guest Editors” was commissioned by the editorial office, Chinese Clinical Oncology without any funding or sponsorship.